Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition.

Zhu J, Hladik F, Woodward A, Klock A, Peng T, Johnston C, Remington M, Magaret A, Koelle DM, Wald A, Corey L.

Nat Med. 2009 Aug;15(8):886-92. doi: 10.1038/nm.2006. Epub 2009 Aug 2.

2.

Virus-specific CD8+ T cells accumulate near sensory nerve endings in genital skin during subclinical HSV-2 reactivation.

Zhu J, Koelle DM, Cao J, Vazquez J, Huang ML, Hladik F, Wald A, Corey L.

J Exp Med. 2007 Mar 19;204(3):595-603. Epub 2007 Feb 26.

3.

Role of Interleukin 32 in Human Immunodeficiency Virus Reactivation and Its Link to Human Immunodeficiency Virus-Herpes Simplex Virus Coinfection.

Mesquita PMM, Preston-Hurlburt P, Keller MJ, Vudattu N, Espinoza L, Altrich M, Anastos K, Herold KC, Herold BC.

J Infect Dis. 2017 Feb 15;215(4):614-622. doi: 10.1093/infdis/jiw612.

PMID:
28007920
4.

Herpes simplex virus type 2-infected dendritic cells produce TNF-α, which enhances CCR5 expression and stimulates HIV production from adjacent infected cells.

Marsden V, Donaghy H, Bertram KM, Harman AN, Nasr N, Keoshkerian E, Merten S, Lloyd AR, Cunningham AL.

J Immunol. 2015 May 1;194(9):4438-45. doi: 10.4049/jimmunol.1401706. Epub 2015 Apr 3.

5.

CCR5 and CXCR4 expression on memory and naive T cells in HIV-1 infection and response to highly active antiretroviral therapy.

Nicholson JK, Browning SW, Hengel RL, Lew E, Gallagher LE, Rimland D, McDougal JS.

J Acquir Immune Defic Syndr. 2001 Jun 1;27(2):105-15.

PMID:
11404531
6.

A novel chemokine-receptor-5 (CCR5) blocker, SCH532706, has differential effects on CCR5+CD4+ and CCR5+CD8+ T cell numbers in chronic HIV infection.

Pett SL, Zaunders J, Bailey M, Murray J, MacRae K, Emery S, Cooper DA, Kelleher AD.

AIDS Res Hum Retroviruses. 2010 Jun;26(6):653-61. doi: 10.1089/aid.2009.0278.

PMID:
20560795
7.

HIV-1 infection impairs HSV-specific CD4(+) and CD8(+) T-cell response by reducing Th1 cytokines and CCR5 ligand secretion.

Rubbo PA, Tuaillon E, Nagot N, Chentoufi AA, Bolloré K, Reynes J, Vendrell JP, BenMohamed L, Van De Perre P.

J Acquir Immune Defic Syndr. 2011 Sep 1;58(1):9-17. doi: 10.1097/QAI.0b013e318224d0ad.

PMID:
21646911
8.

Virologic and immunologic evidence of multifocal genital herpes simplex virus 2 infection.

Johnston C, Zhu J, Jing L, Laing KJ, McClurkan CM, Klock A, Diem K, Jin L, Stanaway J, Tronstein E, Kwok WW, Huang ML, Selke S, Fong Y, Magaret A, Koelle DM, Wald A, Corey L.

J Virol. 2014 May;88(9):4921-31. doi: 10.1128/JVI.03285-13. Epub 2014 Feb 19.

9.

In Situ Detection of Regulatory T Cells in Human Genital Herpes Simplex Virus Type 2 (HSV-2) Reactivation and Their Influence on Spontaneous HSV-2 Reactivation.

Milman N, Zhu J, Johnston C, Cheng A, Magaret A, Koelle DM, Huang ML, Jin L, Klock A, Layton ED, Corey L.

J Infect Dis. 2016 Jul 1;214(1):23-31. doi: 10.1093/infdis/jiw091. Epub 2016 Apr 25.

10.

Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection.

Plana M, García F, Gallart T, Tortajada C, Soriano A, Palou E, Maleno MJ, Barceló JJ, Vidal C, Cruceta A, Miró JM, Gatell JM.

AIDS. 2000 Sep 8;14(13):1921-33.

PMID:
10997396
11.

Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression.

Schacker T, Zeh J, Hu H, Shaughnessy M, Corey L.

J Infect Dis. 2002 Dec 15;186(12):1718-25. Epub 2002 Nov 22.

PMID:
12447756
12.

Homing in on the cellular immune response to HSV-2 in humans.

Koelle DM, Gonzalez JC, Johnson AS.

Am J Reprod Immunol. 2005 Apr;53(4):172-81.

13.

CCR5 and CXCR4 chemokine receptor expression and beta-chemokine production during early T cell repopulation induced by highly active anti-retroviral therapy.

Giovannetti A, Ensoli F, Mazzetta F, De Cristofaro M, Pierdominici M, Muratori DS, Fiorelli V, Aiuti F.

Clin Exp Immunol. 1999 Oct;118(1):87-94.

14.

Breast milk CD4+ T cells express high levels of C chemokine receptor 5 and CXC chemokine receptor 4 and are preserved in HIV-infected mothers receiving highly active antiretroviral therapy.

Kourtis AP, Ibegbu CC, Theiler R, Xu YX, Bansil P, Jamieson DJ, Lindsay M, Butera S, Duerr A.

J Infect Dis. 2007 Apr 1;195(7):965-72. Epub 2007 Feb 20.

PMID:
17330786
15.

HIV-1/HSV-2 co-infected adults in early HIV-1 infection have elevated CD4+ T cell counts.

Barbour JD, Sauer MM, Sharp ER, Garrison KE, Long BR, Tomiyama H, Bassichetto KC, Oliveira SM, Abbate MC, Nixon DF, Kallas EG.

PLoS One. 2007 Oct 24;2(10):e1080.

16.

Immune surveillance by CD8αα+ skin-resident T cells in human herpes virus infection.

Zhu J, Peng T, Johnston C, Phasouk K, Kask AS, Klock A, Jin L, Diem K, Koelle DM, Wald A, Robins H, Corey L.

Nature. 2013 May 23;497(7450):494-7. doi: 10.1038/nature12110. Epub 2013 May 8. Erratum in: Nature. 2013 Aug 8;500(7461):242.

17.
18.

Intravaginal infection with herpes simplex virus type-2 (HSV-2) generates a functional effector memory T cell population that persists in the murine genital tract.

Tang VA, Rosenthal KL.

J Reprod Immunol. 2010 Dec;87(1-2):39-44. doi: 10.1016/j.jri.2010.06.155. Epub 2010 Aug 4.

PMID:
20688399
19.

Impact of asymptomatic Herpes simplex virus-2 infection on T cell phenotype and function in the foreskin.

Prodger JL, Gray R, Kigozi G, Nalugoda F, Galiwango R, Nehemiah K, Kakanga M, Hirbod T, Wawer MJ, Sewankambo N, Serwadda D, Kaul R; Rakai Genital Immunology Research Group.

AIDS. 2012 Jun 19;26(10):1319-22. doi: 10.1097/QAD.0b013e328354675c.

20.

Persistence and emergence of X4 virus in HIV infection.

Weinberger AD, Perelson AS.

Math Biosci Eng. 2011 Apr;8(2):605-26. doi: 10.3934/mbe.2011.8.605.

Supplemental Content

Support Center